ProBioGen AG and Lava Therapeutics B.V. announced the c...
GenScript Biotech Corp., a leading global biotechnology group an...
BioMed X has announced the start of a new joint research group in...
Exonate, a privately held, early stage, biotech company spun out of th...
NBE-Therapeutics AG announces the closing of a USD 22M Series C financ...
Indapta Therapeutics, Inc., a biotechnology company focused on develop...
MedLever announced that it has signed an agreement with RaySearch Labo...
Blueprint Medicines Corporation, a precision therapy company focused o...
BioMed X has announced the start of a new joint research group in...
Schrödinger and Bayer have announced a five-year technology allia...
Lannett Company, Inc. has commenced marketing Venlafaxine Extended Rel...
ProBioGen AG has signed a commercial license agreement with Roche...
genOway, a leading company in the development of genetically modified ...
UK based MiNA Therapeutics has announced the initiation of a research ...
Velabs Therapeutics, a biotech company focused on the rapid screening ...
Polyganics, a medical technology company developing, manufacturing and...
Immunotherapy is forecast to become the oncology treatment of choice b...
Merck, known as MSD outside the United States and Canada, has announce...
